Agilent Technologies, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Agilent Technologies, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 4.7 times. Higher than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Oct 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$133Over the last 3 years, every $100 of reported profit came with $133 of operating cash.
Lower than 62% of Healthcare companies in United States.
Self-Funding Ratio
4.7×Over the last 3 years its own operating cash covered its investment spending (capex) 4.7 times.
Higher than 85% of Healthcare companies in United States.
Cash Locked Ratio
$28For every $100 of sales, $28 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $27 tied up three years earlier.
More money tied up than 61% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
1/3 · 2/3Sales grew in 1 of the last 3 years; profit grew in 2 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales barely changed
Sales changed by +1% in 3 years, too little to measure extra profit per extra sales.
Asset Productivity Ratio
+1% / +21%In 3 years sales changed by +1% while total assets changed by +21%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
5.1×Debt due within a year is covered 5.1 times by its yearly operating cash.
Higher than 80% of Healthcare companies in United States.
Cash Cushion Ratio
−3%Debt, after subtracting cash, equals 3% of its market value (net debt).
Lower than 72% of Healthcare companies in United States.
Tangible Assets Ratio
61%Of every $100 the company owns, $61 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 68% of Healthcare companies in United States.
Tangible Net Worth Ratio
27%Of every $100 of net worth, $27 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 62% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Agilent Technologies, Inc. owes $0.47 for every $1 it owns. Net profit rose 1% in the year to Oct 2025, and grew 1% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Oct 2025.
P/E ratio
34.3Investors pay $34.3 for every $1 of Agilent Technologies, Inc.'s yearly profit, higher than 63% of Healthcare companies in United States.
P/B ratio
6.66The share price is 6.66 times Agilent Technologies, Inc.'s book value per share, higher than 79% of Healthcare companies in United States.
Market cap
$49.0 BThe total market value of all of Agilent Technologies, Inc.'s shares at today's price (share price × number of shares), larger than 96% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$7.4 BWhat Agilent Technologies, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Jul 2026).
Book value per share
$26.11Net worth divided by the number of shares. The share price of $173.89 is 6.7 times this, which is the P/B above.
Return on equity (ROE)
21.0%Agilent Technologies, Inc. earned 21.0% on its shareholders' money over the last year, higher than 91% of Healthcare companies in United States.
Owes vs Owns
0.47×Agilent Technologies, Inc. owes $0.47 for every $1 it owns (low), higher than 53% of Healthcare companies in United States.
Dividend yield
0.57%Agilent Technologies, Inc. pays 0.57% of its share price as dividends a year, lower than 75% of dividend-paying Healthcare companies in United States.
Revenue growth
+7%Revenue rose 7% in the year to Oct 2025, and grew 0% a year on average over 3 years.
Profit growth
+1%Net profit rose 1% in the year to Oct 2025, and grew 1% a year on average over 3 years.
Profit margin
18.8%Agilent Technologies, Inc. keeps $19 of every $100 of revenue as net profit.
Cash quality
1.2×Cash from Agilent Technologies, Inc.'s business was 1.2× its reported profit in the year to Oct 2025 — its profit turned into cash.
Interest cover
13.2×Agilent Technologies, Inc.'s operating profit covered its interest costs 13.2 times in the year to Oct 2025.
Cash vs debt
Net debtAgilent Technologies, Inc. had $1.6 B more debt than cash (net debt) at Oct 2025.
Questions
What is Agilent Technologies, Inc.'s P/E ratio?
Investors pay $34.3 for every $1 of Agilent Technologies, Inc.'s yearly profit, higher than 63% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Agilent Technologies, Inc.: $49.0 B ÷ $7.4 B (31 Jul 2026) = 6.7.
What is Agilent Technologies, Inc.'s return on equity?
Agilent Technologies, Inc. earned 21.0% on its shareholders' money over the last year, higher than 91% of Healthcare companies in United States.
How much does Agilent Technologies, Inc. owe compared with what it owns?
Agilent Technologies, Inc. owes $0.47 for every $1 it owns (low), higher than 53% of Healthcare companies in United States.
Does Agilent Technologies, Inc. pay a dividend?
Yes. Agilent Technologies, Inc. pays 0.57% of its share price as dividends a year, lower than 75% of dividend-paying Healthcare companies in United States.
Is Agilent Technologies, Inc.'s revenue growing?
Revenue rose 7% in the year to Oct 2025, and grew 0% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.